- Home
- ZBIO
ZBIO
ZENAS BIOPHARMA INC
as 04-01-2025 3:45pm EST
Stocks
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 389.2M | IPO Year: | 2024 |
| Target Price: | $32.29 | AVG Volume (30 days): | 196.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -11.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.83 - $26.25 | Next Earning Date: | 05-16-2025 |
| Revenue: | $5,000,000 | Revenue Growth: | -90.00% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest ZENAS BIOPHARMA INC News
ZBIO Breaking Stock News: Dive into ZBIO Ticker-Specific Updates for Smart Investing
Benzinga
13 days ago
Zenas BioPharma Gains Outperform Rating From Analyst As Key Autoimmune Trials Progress
MT Newswires
13 days ago
Wedbush Initiates Zenas BioPharma at Outperform With $35 Price Target
GlobeNewswire
16 days ago
Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
Simply Wall St.
20 days ago
Is Zenas BioPharma (NASDAQ:ZBIO) In A Good Position To Invest In Growth?
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 02/20/2025
GlobeNewswire
2 months ago
Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
MT Newswires
2 months ago
Wolfe Research Initiates Coverage on Zenas BioPharma With Outperform Rating, $19 Price Target
GlobeNewswire
2 months ago
Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference
Compare ZBIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZBIO ZENAS BIOPHARMA INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.